Greenlight Capital (DME) Long / Short David Einhorn · Filed 2026-08-14 · CIK 0001489933 · Q2 2026
Form ADV discretionary AUM, 2026-06-01i
$4.80B
13F Equity Value
$3.91B
As of Q2 2026
13F long book at a glance — % of AUM
GRBK · 16%
FLR
+36 more · 38%
NON-13F · 19%
Holdings Activity Buys Sells History
% of AUMRECOMMENDED % of 13F
# Holding⇕ , sortable Ticker⇕ , sortable Value AUTO FULL K M B
% of AUM↓ , sorted descending # Shares Chg Shares⇕ , sortable % Chg⇕ , sortable % Out⇕ , sortable Source Weight 1 GREEN BRICK PARTNERS INC HIST GRBK $ 757.8M
15.8% 9,467,383 — — 22.01% 13F 2 FLR $ 244.1M
5.1% 4,658,750 (88,600) (1.9%) 3.48% 13F 3 CORE NATURAL RESOURCES INC HIST CNR $ 182.7M
3.8% 2,283,200 +425,060 +22.9% 4.60% 13F 4 BHF $ 179.9M
3.7% 2,842,100 — — — 13F 5 ACADIA HEALTHCARE COMPANY IN HIST ACHC $ 130.0M
2.7% 4,400,641 (117,740) (2.6%) — 13F 6 PENN ENTERTAINMENT INC HIST PENN $ 125.2M
2.6% 5,860,270 (184,170) (3.0%) 4.37% 13F 7 FORTUNE BRANDS INNOVATIONS I HIST FBIN $ 123.1M
2.6% 2,241,875 +2,241,875 NEW 1.88% 13F 8 PCG $ 111.6M
2.3% 6,632,852 — — — 13F 9 CNC $ 106.0M
2.2% 1,651,150 (1,080,660) (39.6%) 0.33% 13F 10 GRAPHIC PACKAGING HLDG CO HIST GPK $ 105.2M
2.2% 9,953,430 +853,450 +9.4% 3.36% 13F 11 TD SYNNEX CORPORATION HIST SNX $ 101.9M
2.1% 381,042 (98,488) (20.5%) 0.48% 13F 12 TEVA PHARMACEUTICAL INDS LTD HIST TEVA $ 97.8M
2.0% 2,886,059 (24,670) (0.8%) 0.25% 13F 13 VGNT $ 95.7M
2.0% 2,277,640 +2,277,640 NEW 3.22% 13F 14 CAPRI HOLDINGS LIMITED HIST CPRI $ 89.5M
1.9% 4,820,118 (110,200) (2.2%) 4.24% 13F 15 BKV $ 84.7M
1.8% 3,095,173 +399,630 +14.8% 2.83% 13F 16 DHT $ 83.2M
1.7% 5,034,320 (238,450) (4.5%) 3.13% 13F 17 CROX $ 80.7M
1.7% 669,140 — — 1.40% 13F 18 ROIV $ 76.2M
1.6% 2,152,669 — — 0.30% 13F 19 SHC $ 73.4M
1.5% 4,135,515 +2,069,835 +100.2% 1.45% 13F 20 VERSANT MEDIA GROUP INC HIST VSNT $ 69.2M
1.4% 1,922,172 (1,106,443) (36.5%) 1.35% 13F 21 PRIMO BRANDS CORPORATION HIST PRMB $ 69.0M
1.4% 2,823,660 +2,823,660 NEW 0.78% 13F 22 DCH $ 67.2M
1.4% 12,395,104 +6,083,754 +96.4% 5.20% 13F +13G 23 PYPL $ 61.5M
1.3% 1,424,320 +1,424,320 NEW — 13F 24 HSIC $ 60.0M
1.3% 718,550 +119,250 +19.9% — 13F 25 WARNER BROS DISCOVERY INC HIST WBD $ 59.9M
1.2% 2,246,180 +2,246,180 NEW 0.09% 13F 26 LBTYA $ 56.4M
1.2% 4,963,322 — — 1.47% 13F 27 ANTERO RESOURCES CORP HIST AR $ 55.3M
1.2% 1,574,140 +765,620 +94.7% 0.51% 13F 28 STUB $ 54.5M
1.1% 4,233,200 — — 1.15% 13F 29 RESIDEO TECHNOLOGIES INC HIST REZI $ 52.9M
1.1% 1,699,590 +124,640 +7.9% 1.12% 13F 30 DECK $ 50.3M
1.0% 506,398 +25,000 +5.2% 0.37% 13F 31 SPECTRUM BRANDS HOLDINGS INC HIST SPB $ 48.1M
1.0% 561,438 (88,921) (13.7%) 2.44% 13F 32 CNH $ 47.0M
1.0% 4,188,940 — — 0.34% 13F 33 VTRS $ 44.0M
0.9% 2,773,470 +955,900 +52.6% 0.24% 13F 34 PARAMOUNT SKYDANCE CORP HIST SKYD $ 38.7M
0.8% 3,926,080 — — 0.37% 13F 35 PVH $ 38.7M
0.8% 520,800 +520,800 NEW 1.13% 13F 36 CMCSA $ 33.0M
0.7% 1,345,780 +1,345,780 NEW 0.07% 13F 37 SLDE $ 32.7M
0.7% 1,686,630 — — 1.44% 13F 38 TRIP $ 32.4M
0.7% 2,361,973 +797,277 +51.0% 2.02% 13F 39 GLD $ 30.7M
0.6% 83,421 (16,190) (16.3%) 0.02% 13F 40 CI $ 24.4M
0.5% 88,400 — — 0.03% 13F 41 LAKEFRONT BIOTHERAPEUTICS NV HIST LKFT $ 14.5M
0.3% 482,746 — — 0.73% 13F 42 COYA THERAPEUTICS INC HIST COYA $ 13.7M
0.3% 2,335,540 — — 9.96% 13F 43 IMVT $ 3.6M
0.1% 93,520 — — 0.05% 13F 44 GPRO $ 1.3M
0.0% 1,693,860 — — 1.07% 13F 45 GAIN THERAPEUTICS INC HIST GANX $ 1.1M
0.0% 566,130 — — 1.30% 13F 46 NUVB $ 0.2M
0.0% 34,995 — — 0.01% 13F Positions are primarily from the latest 13F-HR. Rows marked Off-13F are >5% stakes disclosed in Schedule 13D/13G filings — they capture holdings (incl. recent or non-13F-eligible names) the quarterly 13F may omit; these report shares and percent of class but not dollar value, so value is shown only for 13F positions. Chg Shares is the absolute change vs the same position in the prior quarter's 13F. % Out is position shares ÷ issuer shares outstanding (from the issuer's latest XBRL cover-page figure; weighted-average basic shares as a fallback), or the percent of class reported on a 13D/13G. Where a figure can't be sourced from a filing it shows “—” — never an estimate.
Rockwood Research · Holdings data is sourced from SEC EDGAR 13F-HR filings and XBRL company facts. Capital denominators are reported facts (Form ADV discretionary AUM, total investment portfolio, or shareholders' equity) or omitted, and labelled by source. 13F filings disclose long US-listed equity positions only, on a ~45 day lag. Built with AI and not hand-checked figure-by-figure — verify against the linked filings. Nothing here is investment advice.
© 2026 Rockwood Research · rockwoodresearch.com · Methodology · Privacy · Terms · Rockwood Notes · Rockwood Archive · RSS · Advertising is sold by open auction on the Ad Exchange .